The rise of Sildenafil initially sparked a boom for major pharmaceutical companies, however recent developments present a murky scenario for shareholders. Lower-cost versions are eating into revenue, and continued https://keziaubyf760736.canariblogs.com/sildenafil-and-big-pharma-a-volatile-play-56099848